|
|
Other links at Articles > Cardiology |
| 1. |
Disputed Echo Results From MIST I Require Regulatory Attention, Article States
|
|
|
Dr Jonathan Tobis argues that the FDA and the MHRA in the UK should step in to clear up the "mist of confusion" created by the disparate residual-shunt data reported officially and unofficially for MIST I. While the FDA is refusing to comment, the UK agency says it has reviewed the data and found no sign of safety or efficacy problems with the STARflex device. Heartwire
|
| 2. |
Spotlight on HDL-raising Therapies: Insights From the Torcetrapib Trials
|
|
|
A large trial of a medication designed to raise HDL was stopped early because of a higher risk for death among subjects receiving active treatment. However, HDL-raising therapy may still have an important role in the prevention or management of cardiovascular disease. The current article reviews these treatments. Nature Clinical Practice Cardiovascular Medicine
|
| 4. |
Risk for Metabolic Syndrome Linked to Sleep Duration
|
|
|
A study shows that in patients aged 30 to 54 years, abdominal obesity and elevated glucose are components of the metabolic syndrome most strongly associated with short sleep duration. Medscape Medical News
|
|
|
